Home » Topics » Regulatory

Regulatory
RSS

Continued treatment with Enbrel safe and effective in chronic heart failure

March 16, 2000

New use for teprenone in myocardial preconditioning? Evidence presented at ACC meeting

March 16, 2000

Lilly files NDA for new formulation of Prozac for depression

March 16, 2000

Swedish authorities issue first approval for next-generation PPI

March 15, 2000

Orphan Medical's Busulfex approved in Israel

March 15, 2000

Bioglan Pharma and Sakai to jointly develop ES-Gel aciclovir formulation

March 14, 2000

CE Mark granted for the Prosorba Column as rheumatoid arthritis Rx

March 14, 2000

FDA approval sought for Imitrex in the treatment of adolescent migraine

March 14, 2000

Curatek begins pivotal trial of clonidine gel for neuropathic pain

March 13, 2000

The FDA approves Viadur for once-yearly palliative treatment of advanced prostate cancer

March 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.